Ac Immune Is A Clinical Stage Biopharmaceutical Company Based In Lausanneswitzerlandwith Additional Offices In The United Statesfounded In 2003 By Professor Andrea Pfeiferthe Company Focuses On Precision Medicine For Diagnosingtreatingand Preventing Neurodegenerative Diseasesac Immune Aims To Translate Scientific Discoveries Into Effective Therapiesutilizing A Multidisciplinary Approach That Combines Neuroscienceimmunologyand Drug Discovery The Company Develops Innovative Treatments Through Its Proprietary Technology Platformssupraantigenaand Morphomera These Platforms Enable The Design Of Specific Vaccines And Small Molecules Targeting Misfolded Proteins Associated With Neurodegenerative Diseasesac Immune Has A Strong Pipeline Of Product Candidatesincluding First In Class Vaccines For Alzheimer S Diseasesuch As Aci 24 And Aci 35The Company Collaborates With Leading Pharmaceutical Firms To Enhance Its Drug Development Capabilities And Address The Needs Of Patients Suffering From Neurodegenerative Conditions
